Literature DB >> 6582303

Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine.

R Andreesen, J Osterholz, G A Luckenbach, U Costabel, A Schulz, V Speth, P G Munder, G W Löhr.   

Abstract

Human alveolar macrophages as well as macrophages derived from Teflon culture of blood-borne monocytes were incubated with synthetic analogues of 2-lysophosphatidylcholine and then tested for their cytotoxic capacity against an allogeneic lymphoma cell line. Metabolic, rather stable analogues enhanced macrophage cytotoxicity significantly. This phenomenon was shown both in a growth-inhibition assay as well as in the 51Cr release assay. Macrophage activation was dose- and time-dependent and was potentiated at temperatures above 37 degrees C. Incubation of the macrophages with the active compounds induced characteristic changes in cell morphology as revealed by scanning electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6582303     DOI: 10.1093/jnci/72.1.53

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

Review 1.  Alkylphosphocholines: a new class of membrane-active anticancer agents.

Authors:  P Hilgard; T Klenner; J Stekar; C Unger
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

2.  Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor.

Authors:  F H Valone; N M Ruis
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

3.  Superoxide production by macrophages stimulated in vivo with synthetic ether lipids.

Authors:  B M Schreiber; M D Layne; E J Modest
Journal:  Lipids       Date:  1994-04       Impact factor: 1.880

4.  Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.

Authors:  I Dulisch; H A Neumann; G W Löhr; R Andreesen
Journal:  Blut       Date:  1985-12

5.  Enhanced human monocyte cytotoxicity by platelet-activating factor.

Authors:  F H Valone; R Philip; R J Debs
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

6.  Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment.

Authors:  N Marschner; J Kötting; H Eibl; C Unger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Investigation into the immunological effects of miltefosine, a new anticancer agent under development.

Authors:  P Hilgard; E Kampherm; L Nolan; J Pohl; T Reissmann
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

8.  The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.

Authors:  R W Wilcox; R L Wykle; J D Schmitt; L W Daniel
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

9.  Differential effects of ether lipids on the activity and secretion of interleukin-1 and interleukin-2.

Authors:  R Andreesen; V Giese
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

10.  Immunomodulatory and therapeutic properties of alkyl lysophospholipids in mice.

Authors:  J E Talmadge; M Schneider; B Lenz; H Phillips; C Long
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.